Agennix AG
22Patents
9Active
22Granted
39Portfolio score
Filing activity: Aug 1, 1996 → Sep 8, 2011 · 8 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8048888B2 | Anti-proliferative combination therapy using certain platinum-based chemotherapeutic agents and EGFR inhibitors or pyrimidine analogues | Human Necessities | 24 | Active |
| US5955316A | Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in aspergillus | Chemistry; Metallurgy | 23 | Expired |
| US7420033B2 | Composition of lactoferrin related peptides and uses thereof | Emerging Cross-Sectional Technologies | 21 | Active |
| US6080559A | Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus | Chemistry; Metallurgy | 17 | Expired |
| US7183381B2 | Composition of lactoferrin related peptides and uses thereof | Emerging Cross-Sectional Technologies | 17 | Expired |
| US7238661B2 | Oral lactoferrin in the treatment of respiratory disorders | Human Necessities | 16 | Expired |
| US6399570B1 | Antimicrobial/endotoxin neutralizing polypeptide | Chemistry; Metallurgy | 15 | Expired |
| US7524814B2 | Lactoferrin compositions and methods of wound treatment | Human Necessities | 7 | Expired |
| US7026295B2 | Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease | Human Necessities | 4 | Expired |
| US7323443B2 | Lactoferrin in the reduction of pain | Human Necessities | 4 | Expired |
| US8030272B2 | Lactoferrin compositions and methods of wound treatment | Human Necessities | 3 | Active |
| US7592306B2 | Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease | Human Necessities | 3 | Expired |
| US7034126B2 | Lactoferrin in the treatment of diabetes mellitus | Human Necessities | 2 | Expired |
| US7244706B2 | Antimicrobial/endotoxin neutralizing polypeptide | Chemistry; Metallurgy | 2 | Expired |
| US7901879B2 | Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases | Human Necessities | 1 | Expired |
| US7262279B2 | Lactoferrin in the treatment of diabetes mellitus | Human Necessities | 0 | Expired |
| US8247373B2 | Lactoferrin compositions and methods of wound treatment | Human Necessities | 0 | Active |
| US8105615B2 | Lactoferrin as an adjuvant in cancer vaccines | Human Necessities | 0 | Active |
| US8058234B2 | Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease | Human Necessities | 0 | Active |
| US8304418B2 | Pyrazolopyrimidinone kinase inhibitor | Chemistry; Metallurgy | 0 | Active |
| US7638487B2 | Lactoferrin in the reduction of pain | Human Necessities | 0 | Active |
| US8242079B2 | Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.